Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Curium to acquire Lantheus for enhanced offerings

RECENTLY ACQUIREDAug 03, 2026•6 days ago

Acquiring Company

Curium

Acquired Company

Lantheus Holdings

ParisBedfordManufacturingBiotechnologyHealth CareBiotechnologyHealth CareTherapeutics

Description

Curium is set to acquire Lantheus Holdings, combining their therapeutic capabilities with imaging portfolios. The transaction values Lantheus at up to $114.50 per share, with shareholders receiving $102.50 in cash at closing. The deal aims to maximize shareholder value and bolster the companies' positions in the nuclear medicine market. The merger is expected to close in the first half of 2027, pending approvals.

Company Information

Company

Curium

Location

Paris, Ile De France, France

About

Curium is a world leader in nuclear medicine. We develop, manufacture, and distribute world-class radiopharmaceutical products to help patients around the globe. Our proven heritage combined with a pioneering approach are the hallmarks to deliver innovation, excellence, and unparalleled service. With manufacturing facilities across Europe and the United States, Curium delivers SPECT, PET and therapeutic radiopharmaceutical solutions for life-threatening diseases to over 14 million patients annually. The name ‘Curium’ honors the legacy of pioneering radioactive materials researchers Marie and Pierre Curie, after whom the radioactive element curium was named and emphasizes our focus on nuclear medicine. To learn more, visit www.curiumpharma.com

Related People

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Curium's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.